Search
for
Sort by
Research 391–420 of 874
- SnapshotDx Quiz: August 2016
- Hair & Cutaneous Development
- Changes in eyebrow position following blepharoptosis surgery
- Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation
- Janus kinase inhibitors for alopecia areata
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Hox in hair growth and development
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Aging of the hair follicle pigmentation system
- Genetic interplays between Msx2 and Foxn1 are required for Notch1 expression and hair shaft differentiation
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Human Hair Follicle and Epidermal Melanocytes Exhibit Striking Differences in Their Aging Profile which Involves Catalase
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Characteristics of Androgenetic Alopecia in Asian
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Female pattern alopecia: current perspectives
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Genetic Hair Disorders: A Review
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- Treatments for alopecia areata: A systematic review and network meta‐analysis